April has been one of the most consistently positive months for the S&P 500, but stubborn inflation and elevated valuations present near-term headwinds for stocks.
Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares.
/CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) today announced that its Board of Directors approved a share repurchase program that authorizes the Company to...
/CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $11.1 million or $1.07 basic earnings per share for the...
Moderna's stock surges on positive analyst outlook, reflecting the potential of its innovative mRNA-based vaccines and therapies.
Find out why investment bank analysts are pounding the table on these stocks.
Another analyst became more bearish on its future.
/PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) —...